KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsBuildingsCash & EquivalentsCommon EquityConstruction in ProgressCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityLoans - NetLoans - NetLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesReal Estate - NetReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthpeak Properties (DOC) Preferred Stock Liabilities (2016 - 2026)

Healthpeak Properties has reported Preferred Stock Liabilities over the past 17 years, most recently at $347.3 million for Q4 2025.

  • Quarterly Preferred Stock Liabilities rose 2.78% to $347.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $347.3 million through Dec 2025, up 2.78% year-over-year, with the annual reading at $347.3 million for FY2025, 2.78% up from the prior year.
  • Preferred Stock Liabilities was $347.3 million for Q4 2025 at Healthpeak Properties, up from $343.7 million in the prior quarter.
  • Over five years, Preferred Stock Liabilities peaked at $347.3 million in Q4 2025 and troughed at $199.2 million in Q1 2021.
  • The 5-year median for Preferred Stock Liabilities is $211.8 million (2023), against an average of $258.4 million.
  • Year-over-year, Preferred Stock Liabilities decreased 2.1% in 2021 and then skyrocketed 61.15% in 2024.
  • A 5-year view of Preferred Stock Liabilities shows it stood at $201.1 million in 2021, then decreased by 0.44% to $200.2 million in 2022, then increased by 7.2% to $214.6 million in 2023, then surged by 57.47% to $337.9 million in 2024, then increased by 2.78% to $347.3 million in 2025.
  • Per Business Quant, the three most recent readings for DOC's Preferred Stock Liabilities are $347.3 million (Q4 2025), $343.7 million (Q3 2025), and $340.1 million (Q2 2025).